CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.
Moving Medicine Forward
Claim This Podcastby CTI Clinical Trials
4.9(36 reviews)
66 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
65
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality72
Social0
YouTube68
Engagement77
Podcast Overview
CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.
Language
🇺🇲
Publishing Since
3/8/2024
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
65
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality72
Social0
YouTube68
Engagement77
8
Excellent Areas
2
Good Performance
9
Growth Opportunities
excellent
Episode Length
20 minutes
Performing excellently!
good
Show Experience
29 episodes over 1.5 years
Recommendations available
Unlock the full report to see detailed tips
needs improvement
Publishing Consistency
Every 19 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Moving Medicine Forward
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 23, 2026
Building Better Clinical Trials: Study Start-Up, Patients, and Global Data
<p>What does it take to set a complex global clinical trial up for success? In this episode of Moving Medicine Forward, we are joined by Megan Kamm, Senior Vice President of Client Delivery, and Josh Schroeder, Vice President of Site & Field Operations, to discuss how strong planning, site partnerships, and cross-functional collaboration drive successful trial execution. From feasibility and study startup to patient centered decision-making, biometrics strategy, and global expansion, they share insights into the operational challenge —and opportunities—behind bringing innovative therapies to patients faster. </p><p> </p><p><strong>01:22</strong> Megan Kamm and Josh Schroeder discuss their expanded leadership roles and growing collaboration across teams. </p><p><strong>03:44</strong> Why feasibility, country strategy, and study startup are critical to trial success. </p><p><strong>05:07</strong> The importance of site partnerships, patient experience, and reducing operational burden.</p><p><strong>06:16</strong> How project managers, CRAs, data managers, and site teams work together to execute complex trials. </p><p><strong>07:01</strong> Common startup challenges and strategies for keeping studies on track. </p><p><strong>08:13</strong> Managing patient-centered logistics in rare disease and cell & gene therapy programs. </p><p><strong>11:15</strong> Real-world examples of strong coordination improving enrollment and accelerating timelines. </p><p><strong>13:19</strong> The growing role of biometrics, statistics, and risk-based monitoring in study execution. </p><p><strong>15:15</strong> Scaling global teams through consistent training, leadership alignment, and operational excellence. </p><p><strong>16:48</strong> What differentiates CTI: collaboration, service, and a deep commitment to patients. </p><p><strong>18:59</strong> Looking ahead: AI, technology, startup optimization, and continued global growth. </p><p><strong>21:05</strong> Opportunities and challenges of expanding operations in China and the APAC region.</p>
July 15, 2026
From Australia to China: CTI's APAC Growth Journey
<p>Asia Pacific has become one of the fastest-growing regions in clinical research, offering sponsors new opportunities to advance clinical development in an increasingly complex global environment.</p><p>In this episode, Pavels Anetko, Director of Clinical Operations and Clinical Project Management at CTI, shares insights from across the region, including Australia's strengths in early phase studies and CTI's recent expansion into China and Japan.</p><p> </p><p> </p><p><strong>01:24</strong> Pavels’ background, career journey, and leadership role overseeing CTI's project management teams across Asia Pacific. </p><p><strong>02:13</strong> Why APAC is one of the fastest-growing regions for clinical development and the increasing influence of China. </p><p><strong>02:41</strong> CTI's growth strategy in Australia and the region's advantages for early-phase research, including the CTN regulatory pathway and R&D tax incentives. </p><p><strong>04:06</strong> The rise of healthy volunteer and Phase I studies in Australia. </p><p><strong>04:27</strong> Building CTI's presence in China and Japan and navigating more complex regulatory environments. </p><p><strong>05:05</strong> Staying aligned with regional regulatory requirements while maintaining global clinical trial standards. </p><p><strong>05:40</strong> How CTI helps sponsors select the right countries, sites, and patient populations across APAC. </p><p><strong>06:20</strong> Why local infrastructure, language expertise, and in-country teams are critical to trial success. </p><p><strong>07:09</strong> Challenges sponsors face when entering new APAC markets and how local support reduces risk. </p><p><strong>07:36</strong> The strategic value of including Japan and China in global studies, including access to patients and regulatory considerations. </p><p><strong>08:58</strong> How APAC can accelerate development timelines and strengthen regulatory submissions. </p><p><strong>09:38</strong> Key operational considerations for global studies, including logistics, specimen handling, and country-specific requirements. </p><p><strong>10:08</strong> Emerging opportunities across APAC, including growth in Southeast Asia and expanding clinical research markets. </p><p><strong>10:54</strong> Pavels shares career highlights, including gene therapy studies in Australia and supporting COVID-19 vaccine trials in Singapore. </p><p><strong>12:44</strong> Closing thoughts on the future of APAC and its growing influence on global clinical development.</p>
July 8, 2026
ALK Positive: How Patients are Driving Research
<p>Summer Farmen and Jeff Sturm share their personal cancer journeys and the mission behind ALK Positive, CTI’s Q3 Charity of the Quarter.</p><p>ALK Positive is a patient-driven organization dedicated to improving outcomes for individuals living with ALK-positive cancer.</p><p>Together, they discuss how they became advocates within a global patient community, the importance of genetic testing and second opinions, and the role of research initiatives and clinical trials in advancing treatment options and improving patient outcomes.</p><p><br></p><p><strong>00:00 </strong>Introduction to ALK Positive and today's guests, Summer Farmen and Jeff Sturm. </p><p><strong>01:14</strong> Summer and Jeff share their personal cancer journeys and what led them to become advocates within the ALK Positive community. </p><p><strong>02:33</strong> The mission of ALK Positive: connecting patients, funding research, and ensuring no one faces the diagnosis alone. </p><p><strong>03:49</strong> Why second opinions matter and how specialized expertise can significantly impact treatment decisions. </p><p><strong>06:19</strong> Research initiatives supported by ALK Positive, including clinical trials, grants, and collaborations focused on new treatment approaches. </p><p><strong>10:46</strong> Challenging the perception of ALK-positive cancer as a “rare” disease and advocating for greater representation in research and clinical trials. </p><p><strong>13:22</strong> How targeted therapies have transformed outcomes and extended survival for many ALK-positive patients.</p><p><strong>15:47</strong> The realities of survivorship: managing side effects, quality of life, and the role of palliative care. </p><p><strong>17:27</strong> The importance of genetic testing, monitoring disease progression, and making informed treatment decisions. </p><p><strong>21:15</strong> Clinical trial participation: common barriers, improving access, and helping patients connect with opportunities. </p><p><strong>26:16</strong> Building community through support groups, education programs, Healing Arts initiatives, and patient connections. </p><p><strong>28:46</strong> Addressing the emotional and mental health challenges that often accompany a cancer diagnosis. </p><p><strong>32:50</strong> Looking ahead: emerging therapies, vaccine research, precision medicine, and the future of ALK-positive cancer treatment. </p><p><strong>36:51</strong> Resources available through ALK Positive and how patients and caregivers can get involved. </p><p><strong>37:54</strong> Closing thoughts on advocacy, community, and the patient voices helping shape the future of cancer research. </p>
66 total episodes available
Recent guests on Moving Medicine Forward
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Joel White
Guest
Ryan Gifford
Guest
Lynda Lee Smith
Guest
Jon Koch
Guest
Brian Lawrence
Guest
Dr Sliman
Guest
Robert Wagner
Guest
Halle Raicevich
Guest
Rick Renko
Guest
Alexa Kehoe
Guest
Ricky Renko
Guest
Vincent Drouillon
Guest
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for Moving Medicine Forward
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Moving Medicine Forward?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.